Tevogen Bio Holdings Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Jul 25 · Aug 25 · Sep 25)
Total Assets
$4M
↑+26.6% +$921Kvs FY2024
Total Liabilities
$13M
↑+24.5% +$2Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4M | $3M |
| Current Assets | $2M | $2M |
| Cash | $0 | $0 |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $2M | $2M |
| Non-Current Assets | $3M | $1M |
| PPE | $170K | $296K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $3M | $804K |
| Total Liab+Eq | $4M | $3M |
| Current Liab. | $7M | $9M |
| Accounts Payable | $3M | $5M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $4M | $4M |
| Non-Current Liab. | $6M | $1M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $6M | $1M |
| Equity | $-8M | $-7M |
| Retained Earnings | $140M | $113M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · TVGN · Comparing FY2025 vs FY2024